TIGIT and neoplasm: TIGIT, for instance, suppresses T cell function and controls T cell-mediated and natural killer cell-mediated tumor recognition.[72] Therefore, inhibiting TIGIT selectively may represent a rational strategy for cancer immunotherapy [73].